摘要
Objective. To establish a novel HBV specific immunoadsorbent for the removing of HBV particles. Methods. The anti-HBsAg monoclonal antibody was immobilized on sepharose beads to produce a sepharose anti-HBs column. Then the immunoadsorbent was evaluated and characterized by scanning electron microscopy. In addition, time-dependent effects of the eradication capacity of anti-HBsAg functionalized sepharose beads against HBV were investigated. Results. Proposed immunoadsorbents exhibited a favorable biocompatibility as well as specificity. With the optimized recycle time, the decontamination performance of HBV particles and quantity of HBsAg were assessed either by real-time quantitative PCR or ELISA, which showed that the immunoadsorbent could remove approximately 90% of the HBV and 90% of the HBsAg from human plasma samples. Conclusions. All these results indicated that the novel immunoadsorbent could effectively remove HBV particles and likely serve as a novel therapy option or at least supplementary for the treatment regimen of HBV.
| 源语言 | 英语 |
|---|---|
| 期刊论文编号 | 1269063 |
| 页数 | 7 |
| 期刊 | BioMed Research International |
| 卷 | 2018 |
| DOI | |
| 出版状态 | 已出版 - 1月 2018 |
基金资助
This work was supported by the National Natural Science Foundation of China [Grant no. 81301428 to Li Zhou] and Fundamental Research Funds for the Central Universities [Grants nos. 2042015kf0188 and 2042018kf0034 to Li Zhou].
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
收录
- SCIE
- Scopus
学术指纹
探究 'The Removal of HBV in Plasma by Extracorporeal Immunoadsorption from Plasma: A Potential Therapy of Hepatitis B Patients' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver